Events

Workshop - Forging the future – BE-US joint effort in science for a safer world
JUN
Tue
07
08:30 - 17:30

This was 3 years ago

Location

Royal Military Academy (campus Renaissance)

Royal Military Academy (campus Renaissance)
Rue Hobbema, 8
1000 Brussels
Programmes
Security

The Belgian Royal Higher Institute for Defense, US Army DEVCOM and US Office of Naval Research – Global are organising the first bilateral workshop on defense research

This one-day meeting will provide academic institutions, research institutions and government representatives an opportunity to discuss emerging research and technologies across a broad range of topic areas with a goal of building collaboration across the research community and with government agencies.

More detailed information about this workshop, the preliminary program and the registration form are available here.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.